Bioventus Inc. (BVS)
NASDAQ: BVS
· Real-Time Price · USD
7.21
0.02 (0.28%)
At close: Sep 08, 2025, 3:59 PM
7.34
1.80%
After-hours: Sep 08, 2025, 06:51 PM EDT
Bioventus Revenue Breakdown
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 |
|---|---|---|---|---|---|---|
| International Segment Revenue | 18.89M | 13.36M | 18.43M | 16.05M | 16.81M | 15.18M |
| International Segment Revenue Growth | +41.40% | -27.54% | +14.81% | -4.48% | +10.75% | n/a |
| U.S. Segment Revenue | 128.78M | 110.52M | 135.21M | 122.91M | 134.41M | 114.28M |
| U.S. Segment Revenue Growth | +16.52% | -18.26% | +10.01% | -8.56% | +17.61% | n/a |
Revenue by Geography
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Dec 31, 2021 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 18.89M | 13.36M | 18.43M | 16.05M | 16.81M | 15.18M | 26.9M | 14.57M | 5.42M | 30.16M | 4.41M | 3.24M | 14.02M | 13.21M | 15.24M | 9.73M | 11.13M | 7.24M |
| Non-Us Revenue Growth | +41.40% | -27.54% | +14.81% | -4.48% | +10.75% | -43.58% | +84.66% | +168.57% | -82.02% | +584.72% | +36.08% | -76.91% | +6.15% | -13.34% | +56.69% | -12.63% | +53.78% | n/a |
| United States Revenue | 128.78M | 110.52M | 135.21M | 122.91M | 134.41M | 114.28M | 208.52M | 106.23M | 33.39M | 207.96M | 34.94M | 31.18M | 126.31M | 104.08M | 115.17M | 99.16M | 98.68M | 74.54M |
| United States Revenue Growth | +16.52% | -18.26% | +10.01% | -8.56% | +17.61% | -45.19% | +96.29% | +218.18% | -83.95% | +495.15% | +12.06% | -75.31% | +21.36% | -9.63% | +16.14% | +0.49% | +32.39% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Dec 31, 2021 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 29, 2019 | Mar 31, 2016 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 79.11M | 73.5M | 86.61M | 81.09M | 94.78M | 78.41M | 78.36M | 69.82M | 74.84M | 80.86M | 77.44M | 78.95M | 89.62M | 86.12M | 80.88M | 69.64M | 69.05M | 34.69M | 61.97M | 50.3M | 40.53M | 40.28M | 54.45M | 45.12M | 49.45M | 49.45M | 40.18M | 37.27M |
| Selling, General, and Administrative Revenue Growth | +7.63% | -15.14% | +6.81% | -14.45% | +20.89% | +0.06% | +12.23% | -6.71% | -7.44% | +4.42% | -1.93% | -11.90% | +4.06% | +6.48% | +16.15% | +0.85% | +99.07% | -44.03% | +23.22% | +24.08% | +0.64% | -26.04% | +20.69% | -8.76% | 0.00% | +23.06% | +7.82% | n/a |
| Research and Development Revenue | 3.17M | 3.01M | 3.25M | 3.81M | 3.99M | 2.6M | 3.26M | 3.02M | 3.4M | 3.77M | 6.81M | 4.61M | 6.37M | 6.93M | 7.1M | 6.15M | 4.84M | 947K | 2.89M | 3.57M | 2.6M | 2.15M | 3.14M | 2.85M | 2.53M | 2.53M | 3.72M | 2.97M |
| Research and Development Revenue Growth | +5.35% | -7.24% | -14.76% | -4.51% | +53.56% | -20.39% | +8.19% | -11.27% | -9.89% | -44.60% | +47.53% | -27.52% | -8.11% | -2.46% | +15.44% | +27.23% | +410.67% | -67.24% | -19.00% | +37.48% | +20.97% | -31.74% | +10.51% | +12.41% | 0.00% | -31.93% | +25.35% | n/a |